Rx-to-OTC Switch: The Next Wave
Published December 2002
View PDF brochure
This report provides comprehensive
analyses of 12 therapeutic classes and 36 different drugs to predict their
likelihood for Rx-to-OTC switch in the United States over a five-year
period (2002 to 2006). The study examines potential switches, forecasts
sales, and analyzes the potential impact on the current OTC market. As
a bonus, an overview of several recent switches is provided. (Y406A)
Contact

|